Genoskin is a biotech company that leverages its expertise in skin biology and immunology to enhance the development of medications.
Genoskin has raised $5.4M in total funding. The most recent round was Series A. The last funding was announced in September 2025.
Genoskin's investors include Bpifrance, BNP Paribas, Crédit Agricole, Captech Santé, GSO Innovation.
Genoskin is headquartered in Toulouse, France.
Genoskin is a biotech company that leverages its expertise in skin biology and immunology to enhance the development of medications.
Genoskin is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Genoskin — Funding & Investors." VCBacked, September 16, 2025, https://www.vcbacked.co/company/genoskin. Accessed July 20, 2026.
VCBacked. (2025). Genoskin — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/genoskin
{{cite web |title=Genoskin — Funding & Investors |url=https://www.vcbacked.co/company/genoskin |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated